Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$39.92 - $53.86 $353,172 - $476,499
-8,847 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$48.23 - $66.16 $76,926 - $105,525
1,595 Added 21.99%
8,847 $447,000
Q4 2018

Feb 08, 2019

BUY
$55.63 - $73.24 $403,428 - $531,136
7,252 New
7,252 $426,000
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $515,242 - $658,382
-9,899 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$48.33 - $55.64 $478,418 - $550,780
9,899 New
9,899 $500,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $392M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.